CAM
DMTK

Connacht Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Connacht Asset Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-33,922
Closed -$1.41M – 143
2021
Q2 		$1.41M Sell
33,922
-6,764
-17% -$278K 0.61% 55
2021
Q1 		$2.07M Buy
+40,686
New +$2.13M 0.46% 61

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return

Connacht Asset Management's DMTK Position: Q3 2021 in Review

Connacht Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2021, closing a stake of 33,922 shares — an estimated $1.41M sold.

Connacht Asset Management first reported a position in DMTK in Q1 2021 and held it in 2 quarters. The position peaked at $2.07M in Q1 2021. 162 funds tracked by Wall St. Rank hold DMTK as of Q3 2021.

  • Connacht Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Connacht Asset Management sold 33,922 DermTech, Inc. Common Stock shares in Q3 2021, an estimated $1.41M.
  • Connacht Asset Management first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Connacht Asset Management's DermTech, Inc. Common Stock position peaked at $2.07M in Q1 2021.
  • 162 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2021.

Based on Connacht Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.